THC

Tenet Healthcare Corporation

Healthcare · $20.7B market cap

Verdict

Share price

$258.62

close of Oct 3, 2026

Fair value

$187.27

Sticker Price

Payback Price

$74.91

buy price

Overpriced

THC is Overpriced: at $258.62 it trades 38% above its fair value of $187.27. Its buy price (Payback Price) is $74.91, 71% below today's price. Business quality is solid: 3 of 5 key numbers clear the 10% bar.

How we valued it

Free Cash Flow. Sales grew 4% a year over the last 3 years, below the 15% we look for in a fast grower, so we value it on its free cash flow instead of an earnings forecast.

Business quality

3 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth13.8% a year✓
Equity per share growth5.8% a year✗
Sales growth5.6% a year✗
Free cash flow growth22.3% a year✓
Return on invested capital12.9%✓

Follow THC

Get notified when it reaches its buy price of $74.91. Free.

Create a free account

Superinvestors

3 of the investors we track hold THC. In Q2 2026, 1 added and 1 sold out. Who we track

Moves in Q2 2026

Added: First Eagle Investment Management

Sold out: Stephen Mandel

Insider activity

Since Jul 27, 2026: no open-market purchases, 15 sales worth $44.2M and 1 other filing (stock awards, tax withholding and similar). Why purchases matter

Sales

Other filings

About Tenet Healthcare Corporation

Tenet Healthcare Corporation operates as a broad-ranging provider of health solutions. The company organizes its operations across three main divisions: Hospital Operations and Other, Ambulatory Care, and Conifer. Within its network of acute care facilities, Tenet delivers a full spectrum of essential services. These include core hospital functions such as operating and recovery suites, radiology and respiratory…

Medical - Care Facilities

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works